While reporting financial results for the third quarter on Monday, immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) said it now expects revenues for the full-year 2025 to be between 2.6 billion and 2.8 billion euros, up from the prior forecast range between 1.7 billion to 2.2 billion euros.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.